BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 35897110)

  • 1. A longitudinal assessment of trial protocols approved by research ethics committees: The Adherance to SPIrit REcommendations in the UK (ASPIRE-UK) study.
    Speich B; Odutayo A; Peckham N; Ooms A; Stokes JR; Saccilotto R; Gryaznov D; von Niederhäusern B; Copsey B; Altman DG; Briel M; Hopewell S
    Trials; 2022 Jul; 23(1):601. PubMed ID: 35897110
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Reporting quality of clinical trial protocols: a repeated cross-sectional study about the Adherence to SPIrit Recommendations in Switzerland, CAnada and GErmany (ASPIRE-SCAGE).
    Gryaznov D; von Niederhäusern B; Speich B; Kasenda B; Ojeda-Ruiz E; Blümle A; Schandelmaier S; Mertz D; Odutayo A; Tomonaga Y; Amstutz A; Pauli-Magnus C; Gloy V; Lohner S; Bischoff K; Wollmann K; Rehner L; Meerpohl JJ; Nordmann A; Klatte K; Ghosh N; Taji Heravi A; Wong J; Chow N; Hong P; McCord-De Iaco KA; Sricharoenchai S; Busse JW; Agarwal A; Saccilotto R; Schwenkglenks M; Moffa G; Hemkens L; Hopewell S; Von Elm E; Briel M
    BMJ Open; 2022 May; 12(5):e053417. PubMed ID: 35613804
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Rationale and design of repeated cross-sectional studies to evaluate the reporting quality of trial protocols: the Adherence to SPIrit REcommendations (ASPIRE) study and associated projects.
    Gryaznov D; Odutayo A; von Niederhäusern B; Speich B; Kasenda B; Ojeda-Ruiz E; Blümle A; Schandelmaier S; Mertz D; Tomonaga Y; Amstutz A; Pauli-Magnus C; Gloy V; Bischoff K; Wollmann K; Rehner L; Lohner S; Meerpohl JJ; Nordmann A; Klatte K; Ghosh N; Heravi AT; Wong J; Chow N; Hong PJ; Cord KM; Sricharoenchai S; Busse JW; Agarwal A; Saccilotto R; Schwenkglenks M; Moffa G; Hemkens LG; Hopewell S; von Elm E; Briel M
    Trials; 2020 Oct; 21(1):896. PubMed ID: 33115541
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Reporting quality of trial protocols improved for non-regulated interventions but not regulated interventions: A repeated cross-sectional study.
    Lohner S; Gryaznov D; von Niederhäusern B; Speich B; Kasenda B; Ojeda-Ruiz E; Schandelmaier S; Mertz D; Odutayo A; Tomonaga Y; Amstutz A; Pauli-Magnus C; Gloy V; Bischoff K; Wollmann K; Rehner L; Meerpohl JJ; Nordmann A; Klatte K; Ghosh N; Heravi AT; Wong J; Chow N; Hong PJ; McCord K; Sricharoenchai S; Busse JW; Agarwal A; Saccilotto R; Schwenkglenks M; Moffa G; Hemkens LG; Hopewell S; von Elm E; Blümle A; Briel M
    J Clin Epidemiol; 2021 Nov; 139():340-349. PubMed ID: 34029678
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Nonregistration, discontinuation, and nonpublication of randomized trials: A repeated metaresearch analysis.
    Speich B; Gryaznov D; Busse JW; Gloy VL; Lohner S; Klatte K; Taji Heravi A; Ghosh N; Lee H; Mansouri A; Marian IR; Saccilotto R; Nury E; Kasenda B; Ojeda-Ruiz E; Schandelmaier S; Tomonaga Y; Amstutz A; Pauli-Magnus C; Bischoff K; Wollmann K; Rehner L; Meerpohl JJ; Nordmann A; Wong J; Chow N; Hong PJ; Mc Cord-De Iaco K; Sricharoenchai S; Agarwal A; Schwenkglenks M; Hemkens LG; von Elm E; Copsey B; Griessbach AN; Schönenberger C; Mertz D; Blümle A; von Niederhäusern B; Hopewell S; Odutayo A; Briel M
    PLoS Med; 2022 Apr; 19(4):e1003980. PubMed ID: 35476675
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Not enough SPIRIT shown in the registration and reporting of orthodontic trial protocols.
    Eleftheriadi I; Ioannou T; Katechi V; Seehra J; Pandis N
    Eur J Orthod; 2023 Feb; 45(1):29-37. PubMed ID: 35639885
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Has the reporting quality of published randomised controlled trial protocols improved since the SPIRIT statement? A methodological study.
    Tan ZW; Tan AC; Li T; Harris I; Naylor JM; Siebelt M; van Tiel J; Pinheiro M; Harris L; Chamberlain K; Adie S
    BMJ Open; 2020 Aug; 10(8):e038283. PubMed ID: 32847919
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Shortcomings of protocols of drug trials in relation to sponsorship as identified by Research Ethics Committees: analysis of comments raised during ethical review.
    van Lent M; Rongen GA; Out HJ
    BMC Med Ethics; 2014 Dec; 15():83. PubMed ID: 25490963
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Recommendations and evidence for reporting items in pediatric clinical trial protocols and reports: two systematic reviews.
    Clyburne-Sherin AV; Thurairajah P; Kapadia MZ; Sampson M; Chan WW; Offringa M
    Trials; 2015 Sep; 16():417. PubMed ID: 26385379
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Reporting completeness of nutrition and diet-related randomised controlled trials protocols.
    Silva FM; Amorim Adegboye AR; Curioni C; Gomes F; Collins GS; Kac G; Cook J; Ismail LC; Page MJ; Khandpur N; Lamb S; Hopewell S; Saleh S; Kirtley S; Bernardes S; Durão S; Vorland CJ; Lima J; Rebelo F; Cunha Figueiredo AC; Braga Tibaes JR; Tavares M; da Silva Fink J; Maia de Sousa T; Chester-Jones M; Bi D; Naude C; Schlussel M
    Clin Nutr; 2024 Jul; 43(7):1626-1635. PubMed ID: 38795681
    [TBL] [Abstract][Full Text] [Related]  

  • 11. SPIRIT 2013 Statement: defining standard protocol items for clinical trials.
    Chan AW; Tetzlaff JM; Altman DG; Laupacis A; Gøtzsche PC; Krle A-Jerić K; Hrobjartsson A; Mann H; Dickersin K; Berlin JA; Dore CJ; Parulekar WR; Summerskill WS; Groves T; Schulz KF; Sox HC; Rockhold FW; Rennie D; Moher D
    Rev Panam Salud Publica; 2015 Dec; 38(6):506-14. PubMed ID: 27440100
    [TBL] [Abstract][Full Text] [Related]  

  • 12. SPIRIT 2013 statement: defining standard protocol items for clinical trials.
    Chan AW; Tetzlaff JM; Altman DG; Laupacis A; Gøtzsche PC; Krleža-Jerić K; Hróbjartsson A; Mann H; Dickersin K; Berlin JA; Doré CJ; Parulekar WR; Summerskill WS; Groves T; Schulz KF; Sox HC; Rockhold FW; Rennie D; Moher D
    Ann Intern Med; 2013 Feb; 158(3):200-7. PubMed ID: 23295957
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Systematic evaluation of the patient-reported outcome (PRO) content of clinical trial protocols.
    Kyte D; Duffy H; Fletcher B; Gheorghe A; Mercieca-Bebber R; King M; Draper H; Ives J; Brundage M; Blazeby J; Calvert M
    PLoS One; 2014; 9(10):e110229. PubMed ID: 25333349
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Assessment of clinical trial protocols for pathology content using the SPIRIT-Path guidelines highlights areas for improvement.
    Robinson P; Bacon CM; Lim SJ; Shaaban AM; Brierley D; Lewis I; Harrison DJ; Kendall TJ; Robinson M
    J Pathol Clin Res; 2022 Sep; 8(5):411-421. PubMed ID: 35638866
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Guidelines for cellular and molecular pathology content in clinical trial protocols: the SPIRIT-Path extension.
    Kendall TJ; Robinson M; Brierley DJ; Lim SJ; O'Connor DJ; Shaaban AM; Lewis I; Chan AW; Harrison DJ;
    Lancet Oncol; 2021 Oct; 22(10):e435-e445. PubMed ID: 34592193
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A study protocol for the development of a SPIRIT extension for trials conducted using cohorts and routinely collected data (SPIRIT-ROUTINE).
    McCarthy M; O'Keeffe L; Williamson PR; Sydes MR; Farrin A; Lugg-Widger F; Davies G; Avery K; Chan AW; Kwakkenbos L; Thombs BD; Watkins A; Hemkens LG; Gale C; Zwarenstein M; Langan SM; Thabane L; Juszczak E; Moher D; Kearney PM
    HRB Open Res; 2021; 4():82. PubMed ID: 34877471
    [No Abstract]   [Full Text] [Related]  

  • 17. Prevalence, characteristics, and publication of discontinued randomized trials.
    Kasenda B; von Elm E; You J; Blümle A; Tomonaga Y; Saccilotto R; Amstutz A; Bengough T; Meerpohl JJ; Stegert M; Tikkinen KA; Neumann I; Carrasco-Labra A; Faulhaber M; Mulla SM; Mertz D; Akl EA; Bassler D; Busse JW; Ferreira-González I; Lamontagne F; Nordmann A; Gloy V; Raatz H; Moja L; Rosenthal R; Ebrahim S; Schandelmaier S; Xin S; Vandvik PO; Johnston BC; Walter MA; Burnand B; Schwenkglenks M; Hemkens LG; Bucher HC; Guyatt GH; Briel M
    JAMA; 2014 Mar; 311(10):1045-51. PubMed ID: 24618966
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Resource use, costs, and approval times for planning and preparing a randomized clinical trial before and after the implementation of the new Swiss human research legislation.
    Speich B; Schur N; Gryaznov D; von Niederhäusern B; Hemkens LG; Schandelmaier S; Amstutz A; Kasenda B; Pauli-Magnus C; Ojeda-Ruiz E; Tomonaga Y; McCord K; Nordmann A; von Elm E; Briel M; Schwenkglenks M;
    PLoS One; 2019; 14(1):e0210669. PubMed ID: 30633776
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Identification of ethics committees based on authors' disclosures: cross-sectional study of articles published in the European Journal of Anaesthesiology and a survey of ethics committees.
    Zoccatelli D; Tramèr MR; Elia N
    BMC Med Ethics; 2018 Jun; 19(1):57. PubMed ID: 29884170
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Enhancing reporting through structure: a before and after study on the effectiveness of SPIRIT-based templates to improve the completeness of reporting of randomized controlled trial protocols.
    Blanco D; Donadio MVF; Cadellans-Arróniz A
    Res Integr Peer Rev; 2024 May; 9(1):6. PubMed ID: 38816752
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.